The absence of a prognostic role of YAP1 expression in subests of cancers with identical quantitative Gleason grade highligths the power of the quantitative Gleason grading system49,50, although it is not universally applied and does not overcome all issues connected to interobserver variability in prostate cancer grading. The gene discussed is YAP1; the disease is cancer.